Intravenous pretreatment with empty pH gradient liposomes alters the pharmacokinetics and toxicity of doxorubicin through in vivo active drug encapsulation

Journal of Pharmaceutical Sciences

Volumn 88, Issue 1, 1999, Pages 96-102

  Mayer, Lawrence D ^a   Reamer, Jennifer ^a   Bally, Marcel B ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; LIPOSOME;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; ENCAPSULATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PH MEASUREMENT; TOXICITY TESTING;

EID: 0032958540     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980202h     Document Type: Article

References (27)

1. Mayer, L. D.; Bally, M. B.; Madden, T, D.; Cullis, P. R. pH Gradient Mediated Drug Entrapment in Liposomes. In Liposome Technology; Gregoriadis, G., Ed.; CRC Press: Boca Raton, FL, 1992; Vol. II, pp 27-44.
2. Mayer, L. D.; Cullis, P. R.; Bally, M. B. The Use of Transmembrane pH Gradient-Driven Drug Encapsulation in the Pharmacodynamic Evaluation of Liposomal Doxorubicin. J. Liposome Res. 1994, 4, 529-553.
3. Barenholz, Y.; Crommelin, D.J.A. Liposomes as Pharmaceutical Dosage Forms. In Encyclopedia of Pharmaceutical Technology; Marcel Dekker: New York, 1994; pp 1-39.
4. Mayer, L. D.; Bally, M. B.; Hope, M. J.; Cullis, P. R. Uptake of Antineoplastic Agents into Large Unilamellar Vesicles in Response to Membrane Potentials. Chem. Phys. Lipids 1985, 40, 89-98.
5. Bolotin, E. M.; Cohen, R.; Bar, L. K.; Noam, E.; Ninio, S.; Lasic, D. D.; Barenholz, Y. Ammonium Sulfate Gradients for Efficient and Stable Remote Loading of Amphipathic Weak Bases into Liposomes and Ligandoliposomes. J. Liposome Res. 1994, 4, 455-479.
6. Girard, P. M.; Bouchaud, O.; Goetschel, A.; Mukawaya, G.; Eestermans, G.; Ross, M.; Rozenbaum, W.; Saimot, C. A. G. Phase II Study of Liposomal Encapsulated Daunorubicin in the treatment of AIDS-associated Mucocutaneous Kaposi's Sarcoma. AIDS 1996, 10, 753-757.
7. Janknegt, R. Liposomal Formulations of Cytotoxic Drugs. Support. Care Cancer 1996, 4, 298-304.
8. Lasic, D. D. Doxorubicin in Sterically Stabilized Liposomes. Nature 1996, 380, 561-562.
9. Bally, M. B.; Nayar, R.; Masin, D.; Hope, M. J.; Cullis, P. R.; Mayer, L. D. Liposomes with Entrapped Doxorubicin Exhibit Extended Blood Residence Times. Biochim. Biophys. Acta 1990, 1023, 133-139.
10. Allen, T. M. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharm. Sci. 1994, 15, 215-220.
11. Woodle, Am. C.; Lasic, D. D. Sterically stabilized liposomes. Biochim. Biophys. Acta 1992, 1113, 171-199.
12. Mayer, L. D.; Tai, L. C. L.; Ko, D. S. C.; Masin, D.; Ginsberg, R. S.; Cullis, P. R.; Bally, M. B. Influence of Vesicle Size, Lipid Composition and Drug-to-Lipid Ratio on the Biological Activity of Liposomal Doxorubicin. Cancer Res. 1989, 49, 5922-5930.
13. Mayer, L. D.; Bally, M. B.; Cullis, P. R.; Wilson, S. L.; Emmerman, J. T. Comparison of Free and Liposome Encap-sulated Doxorubicin Entrapped Tumour Drug Uptake and Antitumour Efficacy in the SC115 Murine Mammary Tumour. Cancer Lett. 1990, 53, 183-190.
14. Boman, N. L.; Cullis, P. R.; Bally, M. B.; Mayer, L. D. Preclinical and Clinical Activity of Liposomal Doxorubicin. In Liposomes in Biomedical Applications, Shek, P. N., Ed.; Academic Publishers: Perth, Australia, 1996; pp 85-103.
15. Mayer, L. D.; Hope, M. J.; Cullis, P. R. Vesicles of Variable Sizes Produced by a Rapid Extrusion Procedure. Biochim. Biophys. Acta 1986, 858, 161-168.
16. Mayer, L. D.; Hope, M. J.; Cullis, P. R.; Janoff, A. S. Solute Distributions and Trapping Efficiencies Observed in Freezethawed Multilamellar Vesicles. Biochim. Biophys. Acta 1985, 817, 193-196.
17. Mayer, L. D.; Tai, L. C. L.; Bally, M. B.; Mitilenes, G. N.; Ginsberg, R. S.; Cullis, P. R. Characterization of Liposomal Systems Containing Doxorubicin Entrapped in Response to pH Gradients. Biochim. Biophys. Acta 1990, 1025, 143-151.
18. Van Hossel, Q. G. C. M.; Steerenberg, P. A.; Crommelin, D. J. A.; van Dijk, A.; van Oost, W.; Klein, S.; Douze, J. M. C.; de Wildt, D. J.; Hillen, F. C. Reduced Cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl Rat. Cancer Res. 1984, 44, 3698-3705.
19. Rahman, A.; White, G.; Moore, N.; Schein, P. S. Pharmacological, toxicological and therapeutic evaluation in mice of doxorubicin entrapped in liposomes. Cancer Res. 1985, 45, 796-803.
20. Gabizon, A.; Dagan, A.; Goren, D.; Barenholz, Y.; Fuks, Z. Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res. 1982, 42, 4734-4739.
21. Olson, F.; Mayhew, E.; Maslow, D.; Rustum, Y.; Szoka, F. Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes. Eur. J. Cancer Clin. Oncol. 1982, 18, 167-175.
22. Dvorak, H. F.; Detmar, M.; Claffey, K. P.; Nagy, J. A.; van de Water, L.; Senger, D. R. Vascular permeability factor/ vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int. Arch. Allergy Immunol. 1995, 107, 233-235.
23. Wu, N. Z.; D. D.; Rudoll, T. L.; Needham, D.; Whorton, A. R.; Dewhirst, M. W. Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res. 1993, 53, 3765-3770.
24. Yuan, F.; Leunig, M.; Huang, S. K.; Berk, D. A.; Papahadjopoulos, D.; Jain, R. K. Microvascular permeability and interstitial penetration of sterically stabilized (Stealth) liposomes in a human tumor xenograft. Cancer Res. 1994, 54, 3352-3356.
25. Chang, C. W.; Barber, L.; Ouyang, C.; Masin, D.; Bally, M. B.; Madden, T. M. Comparison of the plasma clearance, biodistribution, and therapeutic properties of mitoxantrone encapsulated in conventional and sterically stabilized liposomes. Br. J. Cancer 1997, 75, 169-177.
26. Webb, M. S.; Harasym, T. O.; Masin, D.; Bally, M. B.; Mayer, L. D. Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumor models. Br. J. Cancer 1995, 72, 896-904.
27. Madden, T. D.; Harrigan, P. R.; Tai, L. C. L.; Bally, M. B.; Mayer, L. D.; Redelmeier, T. E.; Loughrey, H. C.; Tilcock, C. P. S.; Reinish, L. W.; Cullis, P. R. The Accumulation of Drugs Within Large Unilamellar Vesicles Exhibiting a Proton Gradient: A Survey. Chem. Phys. Lipids 1990, 53, 37-46.